Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The price of Ardelyx Inc (NASDAQ: ARDX) closed at $5.13 in the last session, up 16.86% from day before closing price of $4.39. In other words, the price has increased by $16.86 from its previous closing price. On the day, 15.82 million shares were traded. ARDX stock price reached its highest trading level at $5.4899 during the session, while it also had its lowest trading level at $4.96.
Ratios:
We take a closer look at ARDX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.03 and its Current Ratio is at 4.30. In the meantime, Its Debt-to-Equity ratio is 1.48 whereas as Long-Term Debt/Eq ratio is at 1.47.
On May 02, 2025, Raymond James Downgraded its rating to Outperform which previously was Strong Buy but kept the price unchanged to $11.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 16 ’25 when MOTT DAVID M bought 200,000 shares for $3.63 per share. The transaction valued at 725,880 led to the insider holds 2,896,871 shares of the business.
MOTT DAVID M bought 200,000 shares of ARDX for $737,260 on Jun 09 ’25. The Director now owns 2,696,871 shares after completing the transaction at $3.69 per share. On May 20 ’25, another insider, Williams Laura A, who serves as the Chief Medical Officer of the company, sold 6,421 shares for $4.08 each. As a result, the insider received 26,207 and left with 402,583 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARDX now has a Market Capitalization of 1236242816 and an Enterprise Value of 1232193920. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.18 while its Price-to-Book (P/B) ratio in mrq is 8.85. Its current Enterprise Value per Revenue stands at 3.191 whereas that against EBITDA is -32.346.
Stock Price History:
The Beta on a monthly basis for ARDX is 0.70, which has changed by -0.07567567 over the last 52 weeks, in comparison to a change of 0.21149921 over the same period for the S&P500. Over the past 52 weeks, ARDX has reached a high of $7.18, while it has fallen to a 52-week low of $3.21. The 50-Day Moving Average of the stock is 25.79%, while the 200-Day Moving Average is calculated to be 5.48%.
Shares Statistics:
According to the various share statistics, ARDX traded on average about 4.80M shares per day over the past 3-months and 4782690 shares per day over the past 10 days. A total of 240.77M shares are outstanding, with a floating share count of 230.36M. Insiders hold about 3.72% of the company’s shares, while institutions hold 71.98% stake in the company. Shares short for ARDX as of 1752537600 were 27588838 with a Short Ratio of 5.75, compared to 1749772800 on 27283637. Therefore, it implies a Short% of Shares Outstanding of 27588838 and a Short% of Float of 13.059999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The dynamic stock of Ardelyx Inc (ARDX) is currently attracting attention from 4.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.02, with high estimates of $0.04 and low estimates of -$0.05.
Analysts are recommending an EPS of between -$0.22 and -$0.38 for the fiscal current year, implying an average EPS of -$0.33. EPS for the following year is $0.09, with 6.0 analysts recommending between $0.32 and -$0.17.
Revenue Estimates
According to 10 analysts, the current quarter’s revenue is expected to be $101.43M. It ranges from a high estimate of $109.86M to a low estimate of $97.49M. As of the current estimate, Ardelyx Inc’s year-ago sales were $98.24MFor the next quarter, 10 analysts are estimating revenue of $114.64M. There is a high estimate of $127.28M for the next quarter, whereas the lowest estimate is $106.25M.
A total of 10 analysts have provided revenue estimates for ARDX’s current fiscal year. The highest revenue estimate was $408.92M, while the lowest revenue estimate was $378.13M, resulting in an average revenue estimate of $387.84M. In the same quarter a year ago, actual revenue was $333.62MBased on 12 analysts’ estimates, the company’s revenue will be $497.54M in the next fiscal year. The high estimate is $559.8M and the low estimate is $393.7M.
